Equetro review

Equetro, or CBZ, is an anticonvulsant medicament and a mood-stabilizing agent. It acts by decreasing the amount of excitement in the brain and is used for epilepsy and the treatment of bipolar affective disorders. Equetro is effective in controlling seizures by blocking specific brain impulses. It is also used to treat ADD (Attention Deficit Disorder), ADHD (Attention Deficit Hyperactive Disorder), and schizophrenia (a psychiatric condition).

Used alone or combined with other seizure medicaments, Equetro is used to calm manic episodes where the patient exhibits extreme mood swings, mixed episodes of mania and depression, and other abnormal moods.

Equetro can be used in the treatment of trigeminal neuralgia, a condition causing severe pain in the facial nerves. Equetro shifts nerve impulses from the affected facial nerves to ease the pain associated with this condition.

Equetro is also used to treat mental illnesses including depression, post-traumatic stress disorder, withdrawal from medicament and alcohol addictions, restless legs syndrome, diabetes insipidus and a children's disease called chorea.

Patients with bone marrow suppression, porphyria (a blood disorder) and atrioventricular block (a severe heart block problem) should avoid Equetro since the medicament may make their conditions worse. Patients taking antidepressant medicaments including amitriptyline (Elavil), desipramine (Norpramin), imipramine (Trofranil), or nortriptyline (Pamelor) should avoid Equetro to prevent adverse interactions between the medicaments.

Other medicaments that interact negatively with this medicament include cold and allergy medicines, pain relievers, sleeping pills, muscle relaxants, antidepressants like isocarboxazid (Marplan) and phenelzine (Nardil), and anti-anxiety medicines like tranylcypromine (Parnate). Patients taking selegiline, a medicament to treat early-stage Parkinson's disease and senile dementia, should avoid Equetro.

Patients should not consume alcoholic beverages while taking this medicament to avoid the risk of seizures. Patients need to let their physician know if they are taking any prescription or over-the-counter medicaments, including vitamin, mineral or herbal supplements before starting Equetro treatment.

Equetro is classified in pregnancy category D by the FDA. This means that this medicament may harm an unborn baby. Patients who are pregnant, plan to become pregnant or become pregnant during treatment should talk with their physician regarding the risks involved. Since this medicament can be passed on through breast milk and harm nursing infants, patients should refrain from breastfeeding while taking this medicament. Equetro may decrease the effectiveness of hormone-based birth control pills. Patients should talk with their physician regarding alternative birth control options before beginning treatment with this medicament. Equetro may lower the body's natural infection-fighting blood cells. Patients taking this medicament need to have their blood and liver functions checked regularly.

Other side effects include drowsiness, dizziness or headaches, emesis, anxiety, constipation or diarrhea, heartburn, dry mouth, back pain, and impaired motor coordination or unsteadiness of movement. Though rare, Equetro has been known to cause cardiac arrhythmias, blurred eyesight or double vision, and some loss of blood cells or platelets. Consult your physician if you experience any of these symptoms.

Severe side effects including allergic rashes, breathing difficulties, confusion, depression, suicidal thoughts, chest pain, black or tarry stools, jaundice, and losing touch with reality are rare, but are serious and require immediate medical attention.

Equetro is also sold under the brand names Tegretol, Epitol, Finlepsin, Sirtal, Stazepine, Talesmin, Teril, Timonil, Trimonil, and Epimaz. The medicament is available in tablets, chewables, extended-release tablets and capsules, and a liquid (suspension).

Do not stop taking the medicament without consulting your physician. Suddenly stopping Equetro may cause an increase in the number of seizures and produce other unpleasant side effects.

Equetro has the following structural formula:

Chemical structure of equetro

• Molecular formula of equetro is C15H12N2O
• Chemical IUPAC Name is 5H-dibenz[b,f]azepine-5-carboxamide
• Molecular weight is 236.269 g/mol
Equetro available : 100mg tablets, 100mg/5ml suspension, 200mg tablets

Generic name: Carbamazepine

Brand name(s): Atretol, Biston, Calepsin, Carbamazepen, Carbamezepine, Carbatrol, Carbazepine, Carbelan, Epitol, Finlepsin, Karbamazepin, Lexin, Neurotol, Novo-Carbamaz, Nu-Carbamazepine, Sirtal, Stazepin, Stazepine, Taro-Carbamazepine, Tegretal, Tegretol, Telesmin, Teril, Timonil

  Your Equetro review